"Gram-Positive Bacteria" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Bacteria which retain the crystal violet stain when treated by Gram's method.
Descriptor ID |
D006094
|
MeSH Number(s) |
B03.510
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gram-Positive Bacteria".
Below are MeSH descriptors whose meaning is more specific than "Gram-Positive Bacteria".
This graph shows the total number of publications written about "Gram-Positive Bacteria" by people in this website by year, and whether "Gram-Positive Bacteria" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2003 | 3 | 1 | 4 |
2004 | 0 | 1 | 1 |
2005 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2008 | 4 | 1 | 5 |
2009 | 1 | 0 | 1 |
2010 | 1 | 1 | 2 |
2012 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2014 | 2 | 2 | 4 |
2015 | 4 | 0 | 4 |
2016 | 2 | 0 | 2 |
2018 | 1 | 1 | 2 |
2019 | 0 | 2 | 2 |
2020 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gram-Positive Bacteria" by people in Profiles.
-
Hackel MA, Karlowsky JA, Canino MA, Sahm DF, Scangarella-Oman NE. In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes. Antimicrob Agents Chemother. 2022 02 15; 66(2):e0216521.
-
Hassett DJ, Meyer TJ. A Novel Bactericidal Drug Effective Against Gram-Positive and Gram-Negative Pathogenic Bacteria: Easy as AB569. DNA Cell Biol. 2020 Sep; 39(9):1473-1477.
-
Al Rahmany D, Albeloushi A, Alreesi I, Alzaabi A, Alreesi M, Pontiggia L, Ghazi IM. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program. Int J Infect Dis. 2019 Jun; 83:77-82.
-
Facciol? A, Pellican? GF, Visalli G, Paolucci IA, Venanzi Rullo E, Ceccarelli M, D'Aleo F, Di Pietro A, Squeri R, Nunnari G, La Fauci V. The role of the hospital environment in the healthcare-associated infections: a general review of the literature. Eur Rev Med Pharmacol Sci. 2019 Feb; 23(3):1266-1278.
-
Vareechon C, Mestas J, Polanco CM, Dien Bard J. A 5-year study of the performance of the Verigene Gram-positive blood culture panel in a pediatric hospital. Eur J Clin Microbiol Infect Dis. 2018 Nov; 37(11):2091-2096.
-
Nyirjesy P, Schwebke JR. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment. Future Microbiol. 2018 04; 13:507-524.
-
Bensaci M, Sahm D. Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe. Diagn Microbiol Infect Dis. 2017 Feb; 87(2):133-138.
-
Corey GR, Arhin FF, Wikler MA, Sahm DF, Kreiswirth BN, Mediavilla JR, Good S, Fiset C, Jiang H, Moeck G, Kabler H, Green S, O'Riordan W. Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2016 Nov; 48(5):528-534.
-
Relhan N, Albini TA, Pathengay A, Kuriyan AE, Miller D, Flynn HW. Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment. Br J Ophthalmol. 2016 Apr; 100(4):446-52.
-
Hoban D, Biedenbach D, Sahm D, Reiszner E, Iaconis J. Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America - results of AWARE surveillance 2012. Braz J Infect Dis. 2015 Nov-Dec; 19(6):596-603.